Probi AB (publ) (PBBIF)

Market Cap	363.30M
Revenue (ttm)	62.15M
Net Income (ttm)	1.07M
Shares Out	n/a
EPS (ttm)	0.09
PE Ratio	338.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,727
Average Volume	3,050
Open	31.60
Previous Close	24.00
Day's Range	31.60 - 31.60
52-Week Range	17.00 - 25.38
Beta	0.55
RSI	54.69
Earnings Date	Jan 28, 2025

About Probi AB

Probi AB (publ) researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. The company conducts research primarily in the fields of mental, digestive, immune, bone, oral, children’s, women’s, and senior health, as well as iron absorption. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beve...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1991
• Employees: 160
• Stock Exchange: OTCMKTS
• Ticker Symbol: PBBIF

Financial Performance

In 2023, Probi AB's revenue was 627.69 million, an increase of 1.52% compared to the previous year's 618.29 million. Earnings were 16.82 million, a decrease of -58.60%.

Financial numbers in SEK